Allosteric inhibition of Epac: Computationalmodeling and experimental validationtoidentify allosteric sites and inhibitors

Journal of Biological Chemistry

Volumn 289, Issue 42, 2014, Pages 29148-29157

  Brown, Loren M ^a   Rogers, Kathleen E ^a   Aroonsakool, Nakon ^a   McCammon, J Andrew ^a,b,d   Insel, Paul A ^a,c  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; ENERGY TRANSFER; NUCLEOTIDES; PROTEINS;

ALLOSTERIC INHIBITION; ALLOSTERIC MODULATORS; COMPUTATIONAL APPROACH; COMPUTATIONAL MOLECULAR MODELING; GUANINE NUCLEOTIDE EXCHANGE FACTORS; POTENTIAL BINDING SITES; RESONANCE ENERGY TRANSFER; VASODILATOR-STIMULATED PHOSPHOPROTEINS;

BINDING SITES;

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAP1 PROTEIN; THIOBARBITURIC ACID DERIVATIVE; UNCLASSIFIED DRUG; CYCLIC AMP; EPAC PROTEIN, MOUSE; EPAC-1 PROTEIN, RAT; LIGAND; RAPGEF3 PROTEIN, HUMAN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ALLOSTERISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL VIABILITY; COMPUTER MODEL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HINGE REGION; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; LIGAND BINDING; MALE; MIGRATION INHIBITION; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RAT; VALIDATION STUDY; 3T3 CELL LINE; ANIMAL; BINDING SITE; CELL MOTION; CELL SURVIVAL; COMPUTER SIMULATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOUSE; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ALLOSTERIC SITE; ANIMALS; CELL MOVEMENT; CELL SURVIVAL; COMPUTER SIMULATION; CYCLIC AMP; FLUORESCENCE RESONANCE ENERGY TRANSFER; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEK293 CELLS; HUMANS; LIGANDS; MICE; MOLECULAR DYNAMICS SIMULATION; NIH 3T3 CELLS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84908073844     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.569319     Document Type: Article

References (44)

1. Bos, J. L. (2003) Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell Biol. 4, 733-738
2. Schmidt, M., Dekker, F. J., and Maarsingh, H. (2013) Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol. Rev. 65, 670-709
3. Laurent, A. C., Breckler, M., Berthouze, M., and Lezoualc'h, F. (2012) Role of Epac in brain and heart. Biochem. Soc. Trans. 40, 51-57
4. Srivastava, D. P., Woolfrey, K. M., Jones, K. A., Anderson, C. T., Smith, K. R., Russell, T. A., Lee, H., Yasvoina, M. V., Wokosin, D. L., Ozdinler, P. H., Shepherd, G. M., and Penzes, P. (2012) An autism-associated variant of Epac2 reveals a role for Ras/Epac2 signaling in controlling basal dendrite maintenance in mice. PLoS Biol. 10, e1001350
5. Ulucan, C., Wang, X., Baljinnyam, E., Bai, Y., Okumura, S., Sato, M., Minamisawa, S., Hirotani, S., and Ishikawa, Y. (2007) Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 293, H1662-1672
6. Baljinnyam, E., Iwatsubo, K., Kurotani, R., Wang, X., Ulucan, C., Iwatsubo, M., Lagunoff, D., and Ishikawa, Y. (2009) Epac increases melanoma cell migration by a heparan sulfate-related mechanism. Am. J. Physiol. Cell Physiol. 297, C802-813
7. Klein, U., Tu, Y., Stolovitzky, G. A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A., and Dalla-Favera, R. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia revealsahomogeneous phenotype relatedto memory B cells. J. Exp. Med. 194, 1625-1638
8. Lorenz, R., Aleksic, T., Wagner, M., Adler, G., and Weber, C. K. (2008) The cAMP/Epac1/Rap1 pathway in pancreatic carcinoma. Pancreas 37, 102-103
9. Qiao, J., Mei, F. C., Popov, V. L., Vergara, L. A., and Cheng, X. (2002) Cell cycle-dependent subcellular localization of exchange factor directly activated by cAMP. J. Biol. Chem. 277, 26581-26586
10. Consonni, S. V., Gloerich, M., Spanjaard, E., and Bos, J. L. (2012) cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 109, 3814-3819
11. Liu, C, Takahashi, M., Li, Y., Song, S., Dillon, T. J., Shinde, U., and Stork, P. J. (2008) Ras is required for the cyclic AMP-dependent activation of Rap1 via Epac2. Mol. Cell Biol. 28, 7109-7125
12. Harper, S. M., Wienk, H., Wechselberger, R. W., Bos, J. L., Boelens, R., and Rehmann, H. (2008) Structural dynamics in the activation of Epac. J. Biol. Chem. 283, 6501-6508
13. Rehmann, H., Arias-Palomo, E., Hadders, M. A., Schwede, F., Llorca, O., and Bos, J. L. (2008) Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455, 124-127
14. Das, R., Mazhab-Jafari, M. T., Chowdhury, S., SilDas, S., Selvaratnam, R., and Melacini, G. (2008) Entropy-driven cAMP-dependent allosteric control of inhibitory interactions in exchange proteins directly activated by cAMP. J. Biol. Chem. 283, 19691-19703
15. de Rooij, J., Rehmann, H., van Triest, M., Cool, R. H., Wittinghofer, A., and Bos, J. L. (2000) Mechanism of regulation of the Epac family of cAMP-dependentRapGEFs. J. Biol. Chem. 275, 20829-20836
16. Brown, L. M., Rogers, K. E., McCammon, J. A., and Insel, P. A. (2014) Identification and validation of modulators of Epac activity: structurefunction implications for Epac activation and inhibition. J. Biol. Chem. 289, 8217-8230
17. Jiang, L. I., Collins, J., Davis, R., Lin, K. M., DeCamp, D., Roach, T., Hsueh, R., Rebres, R. A., Ross, E. M., Taussig, R., Fraser, I., and Sternweis, P. C. (2007) Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J. Biol. Chem. 282, 10576-10584
18. Swaney, J. S., Roth, D. M., Olson, E. R., Naugle, J. E., Meszaros, J. G., and Insel, P. A. (2005) Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 102, 437-442
19. Matthiesen, K., and Nielsen, J. (2011) Cyclic AMP control measured in two compartments in HEK293 cells: phosphodiesterase K (M) is more important than phosphodiesterase localization. PloS One 6, e24392
20. Franke, B., Akkerman, J. W., and Bos, J. L. (1997) Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBOJ. 16, 252-259
21. Tsalkova, T., Blumenthal, D. K., Mei, F. C, White, M. A., and Cheng, X. (2009) Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities. J. Biol. Chem. 284, 23644-23651
22. Brenke, R., Kozakov, D., Chuang, G. Y., Beglov, D., Hall, D., Landon, M. R., Mattos, C, and Vajda, S. (2009) Fragment-based identification of druggable "hot spots" of proteins using Fourier domain correlation techniques. Bioinformatics 25, 621-627
23. Kozakov, D., Hall, D. R., Chuang, G. Y., Cencic, R., Brenke, R., Grove, L. E., Beglov, D., Pelletier, J., Whitty, A., and Vajda, S. (2011) Structural conservation of druggable hot spots in protein-protein interfaces. Proc. Natl. Acad. Sci. U. S. A. 108, 13528-13533
24. DeLano, W. L. (2012) The PyMOL Molecular Graphics System, version 1.5.0.1, Schroedinger, LLC, New York
25. Roy, A., Kucukural, A., and Zhang, Y. (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725-738
26. Zhang, Y. (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40
27. Schrödinger, LLC (2013) Schrödinger Suite 2013 Protein Preparation Wizard, New York, NY
28. Schrödinger, LLC (2013) Schrödinger Release 2013-3: LigPrep, New York, NY
29. Pastor, R. W., Brooks, B. R., and Szabo, A. (1988) An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol. Phys. 65, 1409-1419
30. Case, D. A., Darden, T. A., Cheatham, T. E., Simmerling, C. L., Wang, J., Duke, R. E., Luo, R., Walker, R. C., Zhang, W., Merz, K. M., Roberts, B., Hayik, S., and Roitberg, A. (2012) AMBER 12, University of California, San Francisco
31. Christen, M., Hünenberger, P. H., Bakowies, D., Baron, R., Bürgi, R., Geerke, D. P., Heinz, T. N., Kastenholz, M. A., Kräutler, V., Oostenbrink, C., Peter, C., Trzesniak, D., and van Gunsteren, W. F. (2005) The GROMOS software for biomolecular simulation: GROMOS05. J. Comput. Chem. 26, 1719-1751
32. Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., and Baker, N. A. (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665-667
33. Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., and Baker, N. A. (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35, W522-525
34. Schrödinger, LLC (2014) Schrödinger Release 2014-1, Maestro, New York, NY
35. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67-73
36. Lin, J. H., Perryman, A. L., Schames, J. R., and McCammon, J. A. (2002) Computational drug design accommodating receptor flexibility: the relaxed complex scheme. J. Am. Chem. Soc. 124, 5632-5633
37. Nichols, S. E., Baron, R., and McCammon, J. A. (2012) On the use of molecular dynamics receptor conformations for virtual screening. Methods Mol. Biol. 819, 93-103
38. Rehmann, H., Schwede, F., Døskeland, S. O., Wittinghofer, A., and Bos, J. L. (2003) Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac. J. Biol. Chem. 278, 38548-38556
39. Courilleau, D., Bisserier, M., Jullian, J. C., Lucas, A., Bouyssou, P., Fischmeister, R., Blondeau, J. P., and Lezoualc'h, F. (2012) Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac. J. Biol. Chem. 287, 44192-44202
40. Yokoyama, U., Patel, H. H., Lai, N. C., Aroonsakool, N., Roth, D. M., and Insel, P. A. (2008) The cyclic AMP effector Epac integrates pro- and antifibrotic signals. Proc. Natl. Acad. Sci. U. S. A. 105, 6386-6391
41. Siegbahn, A., Hammacher, A., Westermark, B., and Heldin, C. H. (1990) Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J. Clin. Invest. 85, 916-920
42. Mark, L. C., Burns, J. J., Brand, L., Campomanes, C. I., Trousof, N., Papper, E. M., and Brodie, B. B. (1958) The passage of thiobarbiturates and their oxygen analogs into brain. J. Pharmacol. Exp. Ther. 123, 70-73
43. Takahashi, M., Rikitake, Y., Nagamatsu, Y., Hara, T., Ikeda, W., Hirata, K., and Takai, Y. (2008) Sequential activation of Rap1 and Rac1 small G proteins by PDGF locally at leading edges of NIH3T3 cells. Genes Cells 13, 549-569
44. Vigil, D., Cherfils, J., Rossman, K. L., and Der, C. J. (2010) Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat. Rev. Cancer 10, 842-857